Nonalcoholic fatty liver disease (NAFLD) is a continuum of liver abnormalities often starting
as simple steatosis and to potentially progress into nonalcoholic steatohepatitis (NASH) …

Nonalcoholic fatty liver disease (NAFLD) is a term used to characterize a range of disease
states that involve the accumulation of fat in the liver but are not associated with excessive …

Purpose: To determine the influence of plaque and progesterone on periodontitis in
pregnant women and their relationship with inflammatory mediators. Materials and Methods …

Background Nonalcoholic fatty liver disease (NAFLD) is primarily characterized by the
hepatic cholesterol accumulation. Circular RNA (circRNA), one of noncoding RNA, involves …

In many developed countries, acetaminophen (APAP) overdose-induced acute liver injury is
a significant therapeutic problem. Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is a …

Introduction: The burden of metabolic (dysfunction) associated fatty liver disease (MAFLD) is
rising mirrored by an increase in hepatocellular cancer (HCC). MAFLD and its sequelae are …

Aims: High plasma concentrations of asymmetric dimethylarginine (ADMA), an endogenous
nitric oxide synthase inhibitor, are associated with hepatic dysfunction in patients with …

The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease - Clinics in Liver Disease Skip
to Main Content Skip to Main Menu Advertisement Clinics in Liver Disease Log in Register …

Abstract Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is an important regulator of
plasma asymmetric dimethylarginine (ADMA) levels, which are associated with insulin …

Background The growing obesity pandemic is the leading cause for increasing prevalence
of nonalcoholic fatty liver disease (NAFLD) in children. Histopathological evaluation of the …